These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25576304)

  • 1. Bypass surgery is more cost-effective than percutaneous coronary interventions for most patients with multivessel or left main coronary artery disease.
    Agarwal S; Kapadia SR
    Evid Based Med; 2015 Apr; 20(2):77. PubMed ID: 25576304
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Al-Atassi et al Regarding Article, "Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial".
    Al-Atassi T; Rodriguez ML; Ruel M
    Circulation; 2015 Jul; 132(1):e10. PubMed ID: 26149431
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery disease: Cost-effectiveness of CABG surgery versus PCI in complex CAD.
    Lim GB
    Nat Rev Cardiol; 2014 Oct; 11(10):557. PubMed ID: 25135118
    [No Abstract]   [Full Text] [Related]  

  • 5. A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.
    Ariyaratne TV; Yap CH; Ademi Z; Rosenfeldt F; Duffy SJ; Billah B; Reid CM
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):261-270. PubMed ID: 29474722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Main Disease: What Is the Correct Approach to Revascularization?
    Rab T; King SB
    Cardiol Rev; 2018; 26(5):219-229. PubMed ID: 29794807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. India and the Coronary Stent Market: Getting the Price Right.
    Wadhera P; Alexander T; Nallamothu BK
    Circulation; 2017 May; 135(20):1879-1881. PubMed ID: 28473448
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
    Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
    Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of everolimus-eluting stents versus first-generation drug-eluting stents in patients with left main coronary artery undergoing percutaneous coronary intervention.
    Capodanno D; Capranzano P; La Manna A; Tamburino C
    Int J Cardiol; 2013 Sep; 168(2):1718-9. PubMed ID: 23642615
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary Syndrome.
    Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    Am J Cardiol; 2017 Aug; 120(3):380-386. PubMed ID: 28595861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.
    Puskas JD; Halkos ME; DeRose JJ; Bagiella E; Miller MA; Overbey J; Bonatti J; Srinivas VS; Vesely M; Sutter F; Lynch J; Kirkwood K; Shapiro TA; Boudoulas KD; Crestanello J; Gehrig T; Smith P; Ragosta M; Hoff SJ; Zhao D; Gelijns AC; Szeto WY; Weisz G; Argenziano M; Vassiliades T; Liberman H; Matthai W; Ascheim DD
    J Am Coll Cardiol; 2016 Jul; 68(4):356-65. PubMed ID: 27443431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis after revascularization for left main coronary artery disease: insights from the crystal ball.
    Byrne RA; Kastrati A
    Eur Heart J; 2015 May; 36(20):1212-5. PubMed ID: 25784753
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic considerations in managing patients with chronic stable angina.
    Nutescu EA
    J Manag Care Pharm; 2006 Oct; 12(8 Suppl):S17-21. PubMed ID: 23577424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery disease: Similar 5-year outcomes with CABG surgery or PCI for left main disease.
    Lim GB
    Nat Rev Cardiol; 2014 Jun; 11(6):312. PubMed ID: 24755917
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-eluting stents in unprotected left main coronary artery disease.
    Bernelli C
    Expert Rev Cardiovasc Ther; 2014 Nov; 12(11):1349-68. PubMed ID: 25340285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry).
    Buchanan GL; Chieffo A; Meliga E; Mehran R; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Narbute I; Makkar RR; Palacios IF; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Allgar V; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    Am J Cardiol; 2014 Apr; 113(8):1348-55. PubMed ID: 24581924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of coronary artery bypass graft and percutaneous coronary intervention compared to medical therapy in patients with coronary artery disease: a systematic review.
    Gholami SS; Azar FEF; Rezapour A; Tajdini M
    Heart Fail Rev; 2019 Nov; 24(6):967-975. PubMed ID: 31179517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.